Small molecule · Inhibitor of L-type calcium channel · developed by Bausch
ApprovedFDA, Nov 1982
1Registered trials
What is Diltiazem?
Diltiazem is a non-dihydropyridine calcium-channel blocker that inhibits calcium ion influx during membrane depolarization in cardiac and vascular smooth muscle. It slows atrioventricular nodal conduction and reduces peripheral vascular resistance. It is used in cardiovascular conditions including supraventricular arrhythmias, atrial fibrillation or flutter, angina and hypertension.
Summary written with AI from the sources listed at the end of this page.
At a glance
Also known as
Cardizem Cd, Diltiazem Hydrochloride, Diltiazem Hydrochloride In Sodium Chloride
Drug type
Small molecule
Targets
L-type calcium channel
Mechanism
Inhibitor of L-type calcium channel
Pathways
calcium influx inhibition during membrane depolarization, AV nodal conduction slowing, peripheral vascular smooth muscle relaxation
Approved as Cardizem Cd, Diltiazem Hydrochloride, Diltiazem Hydrochloride In Sodium Chloride (November 5, 1982), NDA018602 · FDA label
✅ FDA-approved uses
Hypertension (Cardizem Cd)
Chronic stable angina (Cardizem Cd)
Angina due to coronary artery spasm (Cardizem Cd)
Chronic stable angina (Diltiazem Hydrochloride)
Angina due to coronary artery spasm (Diltiazem Hydrochloride)
From the indications section of the FDA label (version of Dec 10, 2025). Read the full label for the exact wording, limitations and safety information.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.